TY - JOUR AU - Schwarz PY - 2018 DA - 2018// TI - Resectable pancreatic adenocarcinoma neo-adjuvant FOLF(IRIN)OX-based chemotherapy - a multicenter, non-comparative, randomized, phase II trial (PANACHE01-PRODIGE48 study) JO - BMC Cancer VL - 18 UR - https://doi.org/10.1186/s12885-018-4663-4 DO - 10.1186/s12885-018-4663-4 ID - Schwarz2018 ER -